Nuclear receptor LXR as a novel therapeutic antitumoral target in glioblastoma

Cancer Discovery

Volumn 1, Issue 5, 2011, Pages 381-382

  Moschetta, Antonio ^a,b  

^a Consorzio Mario Negri Sud ^*  (Italy)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ABC TRANSPORTER A1; CHOLESTEROL; EPIDERMAL GROWTH FACTOR RECEPTOR; FATTY ACID SYNTHASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LAPATINIB; LIVER X RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3, 4, 5 TRISPHOSPHATE 3 PHOSPHATASE; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; ATHEROSCLEROSIS; CANCER CELL; CELL DEATH; CELL PROLIFERATION; CHOLESTEROL SYNTHESIS; GLIOBLASTOMA; HUMAN; HYPERTRIGLYCERIDEMIA; T LYMPHOCYTE; TUMOR GROWTH; UPREGULATION;

CELL DEATH; CHOLESTEROL; GLIOBLASTOMA; HUMANS; LIGANDS; MOLECULAR TARGETED THERAPY; MUTATION; ORPHAN NUCLEAR RECEPTORS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, LDL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 84866696143     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-11-0228     Document Type: Article

References (10)

1. Srere PA, Chaikoff IL, Dauben WG. The in vitro synthesis of cholesterol from acetate by surviving adrenal cortical tissue. J Biol Chem 1948;176:829-33.
2. Siperstein MD, Guest MJ. Studies on the site of the feedback control of cholesterol synthesis. J Clin Invest 1960;39:642-52.
3. Brown MS, Goldstein JL. Suppression of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity and inhibition of growth of human fibroblasts by 7-ketocholesterol. J Biol Chem 1974;249:7306-14.
4. Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science 1986;232:34-47.
5. Bensinger SJ, Bradley MN, Joseph SB, Zelcer N, Janssen EM, Hausner MA, et al. LXR signaling couples sterol metabolism to proliferation in the acquired immune response. Cell 2008;134:97-111.
6. Lo Sasso G, Celli N, Caboni M, Murzilli S, Salvatore L, Morgano A, et al. Down-regulation of the LXR transcriptome provides the requisite cholesterol levels to proliferating hepatocytes. Hepatology 2010;51:1334-44.
7. Yasuda Y, Shimizu M, Shirakami Y, Sakai H, Kubota M, Hata K, et al. Pitavastatin inhibits azoxymethane-induced colonic preneoplastic lesions in C57BL/KsJ-db/db obese mice. Cancer Sci 2010;101:1701-7.
8. Guo D, Reinitz F, Youssef M, Hong C, Nathanson D, Akhavan D, et al. An LXR agonist promotes glioblastoma cell death through inhibition of an EGFR/AKT/SREBP-1/LDLR-dependent pathway. Cancer Discovery 2011;1:442-56.
9. Janowski BA, Willy PJ, Devi TR, Falck JR, Mangelsdorf DJ. An oxysterol signalling pathway mediated by the nuclear receptor LXR alpha. Nature 1996;383:728-31.
10. Repa JJ, Mangelsdorf DJ. The liver X receptor gene team: Potential new players in atherosclerosis. Nat Med 2002;8:1243-8.